What is BIIB's gross margin?

Biogen (BIIB) has a gross margin of 73% and a net margin of 13%.

What is BIIB's P/E ratio?

BIIB's P/E ratio is 20.8 with ROE of 8%.

Where can I see BIIB's full financials?

See Biogen (BIIB) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Biogen (BIIB) Financials — Revenue, Earnings, Cash Flow

Also trades as: 0R1B.L (LSE) · $vol 0M · IDP.DE (XETRA) · $vol 0M · BIIB.SW (SIX)

$193.76

+4.29 (+2.26%)

Weekly Expected Move ±5.8%

$171 $182 $193 $204 $215

NASDAQ · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 58 · $28.6B mcap · 146M float · 0.786% daily turnover · Short 62% of daily vol

📊 Key Metrics

TTM

$10B

Revenue

+0.4% YoY

$1B

Net Income

-7.2% YoY

$3B

Free Cash Flow

+14.3% YoY

73.3%

Gross Margin

16.0%

Op. Margin

12.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE7.8%

ROA4.8%

ROIC6.7%

Valuation

P/E20.8

P/B1.5

EV/EBITDA10.9

Leverage

Debt/Equity0.38

Current Ratio2.68

Interest Cov.6.9x

Quality Scores

Piotroski F5/9

Altman Z3.21

Beneish M-2.66